Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.

MLA

Goos, Tinne, et al. “Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.” Journal of Clinical Medicine, vol. 10, no. 6, Mar. 2021. EBSCOhost, https://doi.org/10.3390/jcm10061330.

APA

Goos, T., De Sadeleer, L. J., Yserbyt, J., Verleden, G. M., Vermant, M., Verleden, S. E., & Wuyts, W. A. (2021). Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be. Journal of Clinical Medicine, 10(6). https://doi.org/10.3390/jcm10061330

Chicago

Goos, Tinne, Laurens J De Sadeleer, Jonas Yserbyt, Geert M Verleden, Marie Vermant, Stijn E Verleden, and Wim A Wuyts. 2021. “Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.” Journal of Clinical Medicine 10 (6). doi:10.3390/jcm10061330.